You Save:
Inclusive of all taxes
Product not available
Panmad IV Injection is a medicine that reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine such as acid reflux, peptic ulcer disease, Zollinger-Ellison syndrome. It provides relief from symptoms and promotes healing.
Panmad IV Injection is also used to prevent stress ulcers in seriously ill patients and is administered before anesthetic medication to help prevent aspiration-related complications. It belongs to a class of medicines known as proton pump inhibitors (PPIs).
Country Of Origin : India
Panmad IV Injection is a versatile and crucial medication formulated for the effective management of acid-related diseases of the stomach and intestine. With its potent formula, Panmad IV Injection is particularly beneficial for conditions such as acid reflux, peptic ulcer disease, and Zollinger-Ellison syndrome. It is a member of the class of medicines known as proton pump inhibitors (PPIs), which adeptly works by reducing the quantity of acid produced in the stomach, thereby relieving symptoms and promoting healing.
Acid reflux is a condition where stomach acid frequently flows back into the tube connecting your mouth and stomach. This backwash can irritate the lining of your esophagus and cause discomfort. Panmad IV Injection provides swift relief by reducing stomach acid production, thereby alleviating the associated discomfort and symptoms.
Peptic ulcers are open sores that develop on the inside lining of your stomach and the upper portion of your small intestine. Panmad IV Injection aids in the reduction of stomach acid, thus promoting an environment conducive to the healing of these ulcers and preventing further irritation.
Zollinger-Ellison syndrome causes tumors in the pancreas and duodenum, leading to excessive acid production. Panmad IV Injection mitigates the high levels of stomach acid, controlling symptoms and preventing complications associated with the syndrome.
Stress ulcers are a common issue among seriously ill patients due to the increased stress and physiological demands on their bodies. Panmad IV Injection is employed as a preventive measure to reduce the risk of stress ulcers by managing stomach acid production effectively.
Prior to undergoing surgery, it is crucial to prevent aspiration-related complications. Panmad IV Injection is administered before anesthesia to reduce stomach acid and consequently lower the risk of aspiration, ensuring a safer surgical experience.
Panmad IV Injection operates as a proton pump inhibitor (PPI). PPIs are highly effective in controlling gastric acid secretion by irreversibly blocking the enzyme system of hydrogen/potassium adenosine triphosphatase (H+/K+ ATPase), known as the gastric proton pump, found in the stomach lining. This action significantly reduces gastric acid production, thereby providing relief from acid-related symptoms and promoting recovery of the gastric mucosa.
Panmad IV Injection is tailored for intravenous (IV) administration, ensuring rapid onset of action. The intravenous route is particularly advantageous in acute settings or for patients who may have difficulty swallowing oral medications. It is crucial that administration is conducted by a healthcare professional to ensure accurate dosage and effective results.
The precise dosage of Panmad IV Injection is determined by several factors, including the condition being treated, its severity, and the patient’s overall health status. Healthcare providers will personalize the dosage regimen to suit individual patient needs, ensuring optimal therapeutic outcomes.
Patients with a known allergy to proton pump inhibitors or any component of Panmad IV Injection should avoid its use and consult their healthcare provider for alternative treatments.
Patients with severe liver problems, or those who have a history of specific health conditions, should inform their healthcare provider, as dose adjustments or special monitoring might be required.
Panmad IV Injection could interact with other medications. It is vital to disclose all medications, including over-the-counter drugs and supplements, to the healthcare provider to avoid potential adverse interactions.
Some patients may experience common side effects such as headache, diarrhea, nausea, vomiting, flatulence, dizziness, and abdominal pain. These tend to be mild and transient.
Though rare, serious side effects may occur, including severe allergic reactions, bone fracture risk with long-term use, vitamin B12 deficiency, and Clostridium difficile infection in the colon. Immediate medical attention is warranted if severe reactions are noted.
Panmad IV Injection should be stored in a cool and dry place, protected from light and moisture. It must be stored out of reach of children and only used under medical supervision.
Healthcare professionals must ensure proper handling techniques to maintain the medicine's efficacy and sterility. Any unused medicine should be disposed of in accordance with local regulations to prevent misuse or environmental harm.
Panmad IV Injection has been extensively studied in clinical trials, showcasing its efficacy in reducing gastric acid secretion and managing acid-peptic diseases. The studies have highlighted its benefits in both short-term relief and long-term management of the aforementioned conditions.
In clinical practice, Panmad IV Injection has proven to be a reliable therapeutic option, providing effective symptom relief and promoting mucosal healing. Its role in
